Press Releases

PARIS--(BUSINESS WIRE)-- ESI Group (Paris:ESI), leading innovator in

SALT LAKE CITY--(BUSINESS WIRE)-- BioUtah, Utah’s only trade association dedicated solely to the life sciences community, kicks-offs its 9th annual Utah Life Sciences Summit November 1, presented by

VANCOUVER, Wash.--(BUSINESS WIRE)-- RealWear, Inc. today announced the hiring of Michael Guerchon as Vice President, Human Resources. Guerchon brings more than 25 years of experience across a variety of growth-oriented companies leading HR and culture initiatives. This press release features multimedia. View the full release here:

SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced positive top-line results from CLARITY, a randomized, double-blind, placebo-controlled, multi-center, sequential parallel comparison design (SPCD) study in major depressive disorder (MDD). In the study, 207 adult patients with a confirmed inadequate response to existing first-line SSRI or SNRI therapy for MDD received adjunc

PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the license agreement and research collaboration and option agreement between Arrowhead and Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the stock purchase agreement between Arrowhead and Johnson & Johnson Innovation – JJDC, Inc., (JJDC) ha

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq:CERS) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the Company’s pathogen-reduced cryoprecipitate product candidate. The basis of the designation is improved treatment of massive hemorrhage, a life-threatening medical condition. "The proposed label indication for path

NEW YORK--(BUSINESS WIRE)-- Alliance MMA, Inc. (NASDAQ: AMMA) announced the appointment of Charles K. Miller to its Board of Directors, including its Compensation and Audit Committees. The Board of Directors appointed Mr. Miller because of his strong corporate governance, business finance and technology expertise, all of which skills will be essential upon completion of the Company’s previously announced

HOUSTON--(BUSINESS WIRE)-- Enterprise Products Partners L.P. (NYSE: EPD) today announced plans for an incremental 150,000 barrels per day (“BPD”) expansion to its natural gas liquids (“NGL”) fractionation facilities at its Mont Belvieu complex. The expansion would increase Enterprise’s NGL fractionation capacity to 1 million BPD in the Mont Belvieu area, and approximately 1.5 milli

NEW YORK--(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ: OPHT) announced today that it has acquired Inception 4, Inc., a privately held company backed by Versant Ven

NEW YORK--(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that it has entered into an exclusive option agreement with the University of Pennsylva

NEW YORK--(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced financial and operating results for the third quarter ended September 30, 2018 and prov

SAN DIEGO & NASHVILLE, Tenn.--(BUSINESS WIRE)-- In the wake of a record-breaking $16 million data breach settlement earlier this month that put insurers and provides alike on notice that ignoring cybersecurity risks could come with a hefty price tag, a new national survey of U.S. health systems finds that only 29 percent report having a comprehensive cybersecurity program in place. “Due to

PETACH TIKVA, Israel--(BUSINESS WIRE)-- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small mol

FOSTER CITY, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics, Inc., a company focused on the discovery and development of novel cancer therapies, today announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted immuno-oncology treatments for patients with cancer. This pre

LOS ANGELES--(BUSINESS WIRE)-- Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has entered into an agreement with Capital BlueCross, a community-based health insurer serving members in 21 counties in Central Pennsylvania and the Lehigh Valley. Beginning the first quarter of 2019, eligible Capital B